Short-term adverse effects of testosterone used for priming in prepubertal boys before growth hormone stimulation

Andrea Albrecht1, Theresa Penger1, Michaela Marx1

  • 1Paediatric Endocrinology, Department of Paediatrics and Adolescent Medicine, University Hospital of Erlangen, Erlangen, Germany.

Insights

Priming prepubertal boys with testosterone before growth hormone tests is generally safe, with a low 2.7% side effect rate including priapism and testicular pain. Doses and testosterone levels did not correlate with adverse events.

Area of Science:

  • Pediatric Endocrinology
  • Pharmacology
  • Clinical Trial Analysis

Background:

  • Prepubertal children often receive sex steroid priming before growth hormone (GH) provocative testing.
  • Controversy exists regarding optimal priming protocols (age, drug, dose, timing).
  • Safety data on testosterone priming for GH testing is limited.

Observation:

  • 188 short-statured prepubertal boys received testosterone enanthate priming before GH testing.
  • Doses administered were 50 mg (n=136), 125 mg (n=51), and 250 mg (n=1).
  • Serum testosterone levels were measured in 99 boys on the day of the GH test.

Findings:

  • Overall adverse event rate was 2.7% (5 out of 188 boys).
  • Reported side effects included priapism and testicular pain.
  • No correlation found between testosterone dose, serum testosterone levels, and adverse outcomes.

Implications:

  • Parents and patients should be informed of potential side effects like priapism and testicular pain.
  • Testosterone priming appears to have a low overall risk profile for GH testing.
  • Current evidence suggests dose and serum levels do not predict adverse events.
Abstract

Related Concept Videos

Signs of Puberty01:27

Signs of Puberty

Puberty is a critical phase, typically beginning between the ages of 8 and 13 in girls and 9 and 14 in boys, though timing can vary based on genetics, environmental factors, and overall health. This period is characterized by the development of secondary sexual characteristics and the attainment of reproductive potential. Endocrine changes underpin puberty, with hormonal surges of Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH) instigated by Gonadotropin-Releasing Hormone (GnRH)...
1.6K
Testosterone: Functions and Regulation01:26

Testosterone: Functions and Regulation

The intricate hormonal interplay essential for male reproductive health begins with the release of gonadotropin-releasing hormone (GnRH) by the hypothalamus. This hormone prompts the pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). LH targets the Leydig cells in the testes, stimulating them to produce and release testosterone. In concert with testosterone, FSH acts on the Sertoli cells within the seminiferous tubules to facilitate the release of...
2.4K
Disorders of the Male Reproductive System01:20

Disorders of the Male Reproductive System

Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
5.2K
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
864